SCHEMBL16634792

SCHEMBL16634792

CCCCCSOc1ccccc1C(N)=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.62
LMNA P02545 2/20 0.62
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
NR1I2 O75469 1/20 0.62
CHRM2 P08172 1/20 0.62
ADRA2A P08913 1/20 0.62
MAPT P10636 1/20 0.62
OPRK1 P41145 1/20 0.62
HTR2B P41595 1/20 0.62
SLC6A3 Q01959 1/20 0.62
HDAC6 Q9UBN7 1/20 0.62
CTNNB1 P35222 1/20 0.47
IRAK4 Q9NWZ3 1/20 0.46
PTGS2 P35354 4/20 0.46
HTT P42858 1/20 0.44
TSHR P16473 3/20 0.43
TP53 P04637 1/20 0.43
MAPK1 P28482 1/20 0.43
ALDH1A1 P00352 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9770284 0.85 KMT2A (0.55) CYP3A4LMNAMEN1KMT2ANR1I2
SCHEMBL6990857 0.85 KMT2A (0.55) CYP3A4LMNAMEN1KMT2ANR1I2
SCHEMBL9770258 0.85 KMT2A (0.55) CYP3A4LMNAMEN1KMT2ANR1I2
SCHEMBL29204962 0.79 PTGS2 (0.42) CYP3A4LMNAMEN1KMT2ANR1I2
Pentalamide SCHEMBL1262590 0.78 LMNA (0.97) CYP3A4LMNAMEN1KMT2ANR1I2
Pentalamide SCHEMBL30575479 0.78 LMNA (0.97) CYP3A4LMNAMEN1KMT2ANR1I2
Exalamide SCHEMBL151112 0.77 LMNA (1.00) CYP3A4LMNAMEN1KMT2ANR1I2
SCHEMBL5147507 0.77 LMNA (1.00) CYP3A4LMNAMEN1KMT2ANR1I2
SCHEMBL873025 0.77 LMNA (1.00) CYP3A4LMNAMEN1KMT2ANR1I2
SCHEMBL4656110 0.77 LMNA (1.00) CYP3A4LMNAMEN1KMT2ANR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015054337-A1 HETEROCYCLIC COUPLING CATALYSTS AND METHODS RELATED THERETO EMORY UNIVERSITY (US) 2015-04-16 WO disclosed